The GLP is committed to full transparency. Download and review our Annual Report.

Cancer has a male bias and we’re just starting to understand why

| | April 19, 2019

More than half of neurooncologist Josh Rubin’s pediatric brain cancer patients over his 25-year career have been boys.

About a decade ago, curious if his and his colleagues’ experiences were backed by data, Rubin turned to national registries for cancer incidence and outcome. The data revealed that, “indeed, for decades it’s been documented that . . . overall, males get more cancer than females,” he says.

Over the past few years, researchers have begun to characterize cancer-linked cellular differences between males and females. In 2017, for example, a group at Harvard Medical School and the Broad Institute of Harvard and MIT identified a handful of tumor suppressor genes that escape X-chromosome inactivation in tumor cells from female patients, and are thus more highly expressed in females than in males. Carrying two copies of the X chromosome gives females a “double dose” of the tumor suppressors compared with levels resulting from the single gene in XY males.

Related article:  Viewpoint: Here’s how activists manipulate cell phone cancer risk statistics to fool regulators

“In an era where people love to talk about personalized medicine, [the fact] that personalizing to a person’s sex has not been part of that conversation is incredible to me,” [says Rubin.]

Read full, original post: Why Is Cancer More Common in Men Than in Women?

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend